Sindrome.del.Ovario.Poliquistico

142 Síndrome del Ovario Poliquístico
ment. Hum Reprod Update. 2004;10:
267-70.
10
Pasqualli R, Gambineri A. Role of changes
in dietary habits in polycystic ovary
syndrome. Reprod Biomed Online. 2004;
8:431-9.
11
Moran L, Norman RJ. Understanding
and managing disturbances in insulin
metabolism and body weight in women
with polycystic ovary syndrome. Best
Practice Research. 2004;18:719-26.
12
Lord JM, Flight IHK, Norman RJ. Metformin
in polycystic ovary syndrome:
systematic review and meta-analysis.
BMJ. 2003;327:951-6.
13
Brown JB. Pituitary control of ovarian
function concepts derived from gonadotrophin
therapy. Aust NZ J Obstet
Gynaecol. 1978;18:47-54.
14
Fauser B, Van Heusden A. Manipulation
of Human Ovarian Function: Physiological
Concepts and Clinical Consequences.
Endocr Rev. 1997;18:71-6.
15
Adashi E. Ovulation Induction: Clomiphene
Citrate. In: Adashi E, Rock
J, Rosenwaks Z, editors. Reproductive
Endocrinology, Surgery and Technology.
Vol. 1. New York: Lippincott-Raven;
1995. p. 1181.
16
Homburg R. The management of infertility
associated with polycystic ovary
syndrome. Reprod Biol Endocrinol.
2003;1:109. Review.
17
Eijkemans MJ, Imani B, Mulders AG,
Habbema JD, Fauser BC. High singleton
live birth rate following classical ovulation
induction in normogonadotrophic
anovulatory infertility (WHO 2). Hum
Reprod. 2003;18:2357-66.
18
Balen AH, Braat DD, West C, Patel A,
Jacobs HS. Cumulative conception and
live birth rates after treatment of anovulatory
infertility: Safety and efficacy
of ovulation induction in 200 patients.
Human Reprod. 1994;9:1563-70.
19
Nasseri S, Ledger WL. Clomiphene Citrate
in the twenty-first century. Human
Fertil (Camb). 2001;4:145-51.
20
Imani B, Eijkemans MJ, te Velde ER,
Habbema JD, Fauser BC. Predictors of
patients remaining anovulatory during
clomiphene citrate induction of ovulation
in normogonadotropic oligoamenorrheic
infertility. Clin Endocrinol Metab.
1998;83:2361-5.
21
Imani B, Eijkemans MJ, te Velde ER,
Habbema JD, Fauser BC. Predictors of
chances to conceive in ovulatory patients
during clomiphene citrate induction of
ovulation in normogonadotropic oligoamenorrheic
infertility. J Clin Endocrinol
Metab. 1999;84:1617-22.
22
Imani B, Eijkemans MJ, De Jong FH,
Payne NN, Bouchard P, Giudice LC, et
al. Free androgen index and leptin are
the most prominent endocrine predictors
of ovarian response during clomiphene
citrate induction of ovulation in
normogonadotropic oligoamenorrheic
infertility. J Clin Endocrinol Metab.
2000;85:676-82.
23
Kashyap S, Wells GA, Rosenwaks Z.
insulin-sensitizing agents as primary
therapy for patients with polycystic
ovarian syndrome. Human Reprod. 2004;
19:2474-83.
24
Polson D, Kiddy D, Mason H, Franks S.
Induction of ovulation with Clomiphene
Citrate in women with polycystic ovary
syndrome: The difference between
responders and non responders. Fertil
Steril. 1989;51:30-4.
25
Agrawal SK, Buyalos RP. Corpus luteum
function and pregnacy rates with clomiphene
citrate therapy: comparison of
human chorionic gonadotrophin-induced
versus spontaneous ovulatio. Human
Reprod. 1995;10:328-31.
26
Mitwally MF, Casper RF. Use of an
aromatase inhibitor for induction of
ovulation in patients with an inadequate
response to clomiphene citrate. Fertil
Steril. 2001;75:305-9.
27
Mitwally MF, Casper RF. Aromatase
inhibitors for the treatment of infertility.
Expert Opin Investig Drugs. 2003;12:
353-61. Review.